Maturity-onset diabetes of the young type 5: a case report
Keywords:
Diabetes MODY-5.Abstract
MODY-5 diabetes is an infrequent type of monogenic diabetes, caused by mutation in the gene of the nuclear hepatic transcription factor 1-beta (HNF-1β). This mutation can be of a momentary type or it might correspond to big deletions, and, in its turn, it can appear due to spontaneous de novo mutation or it can be transmitted by hereditary with an autosomal dominant character. It is associated with a high risk of microvascular complications that appear early in affected people, as well as with characteristic renal alterations of the cyst type, and anomalies of the genital tract, which are present even before birth. That is why it is justified to carry out detection tests for HNF-1β mutations in non-obese diabetics, above all when there are associated renal or genital alterations, without consideration of family antecedents.Downloads
References
1. IWASAKI N, OGATA M, TOMONAGA O, KUROKI H, KASAHARA T, YANO N. Liver and kidney function in Japanese patients with maturity-onset diabetes of the young. Diabetes Care 2001; 21: 2144-2148.
https://doi.org/10.2337/diacare.21.12.2144
2. NISHIGORI H, YAMADA S, KOHAMA T, TOMARA H, SHO K, HONIKAWA Y. Frameshift mutation, A263fsinsGG, in hepatocyte nuclear factor-1beta gene associated with diabetes and renal dysfunction. Diabetes 1998; 47: 1354-1355.
https://doi.org/10.2337/diabetes.47.8.1354
3. SÁNCHEZ-REYES L, FANGHÄNEL G, MÁRQUEZ-CID ME, SALAZAR R, LABASTIDA-SÁNCHEZ C, SOLÍS-PÉREZ A et al. Actualización en los diferentes subtipos de diabetes tipo "MODY". Endocrinol Nutr 2001; 9: 5-11.
4. FAJANS SS, BELL GI, POLONSKY KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001; 345: 971-980.
https://doi.org/10.1056/NEJMra002168
5. BARRIO R. Diabetes monogénicas: enfoque diagnóstico y tipos más frecuentes. Av Diabetol 2007; 23: 333-340.
6. BELLANNÉ-CHANTELOT C, CHAUVEAU D, GAUTIER JF, DUBOIS-LAFORGE D, CLAUIN S, BEAUFILS S et al. Clinical spectrum associated with hepatocyte nuclear factor-1beta mutations. Ann Intern Med 2004; 140: 510-517.
https://doi.org/10.7326/0003-4819-140-7-200404060-00009
7. VELHO G, BELLANNÉ-CHANTELOT C, TIMSIT J. Heterogeneidad de MODY y conducta clínica. ¿Diferentes genes como guía de distintos enfoques? Endocrinol Nutr 2004; 5 (Suppl. 2): 22S-30S.
8. HIESBERGER T, BAI Y, SHAO X, MCNALLY BT, SINCLAIR AM, TIAN X, et al. Mutation of hepatocyte nuclear factor-1-beta inhibits Pkhd1 gene expression and produces renal cyst in mice. J Clin Invest 2004; 113: 814-825.
https://doi.org/10.1172/JCI200420083
9. BELLANNÉ-CHANTELOT C, CLAUIN S, CHAUVEAU D, COLLIN P, DAUMONT M, DOUILLARD C, et al. Large genomic rearrangements in the hepatocyte nuclear factor-1beta (TCF2) gene are the most frequent cause of maturity-onset diabetes of the young type 5. Diabetes 2005; 54: 3126-3132.
https://doi.org/10.2337/diabetes.54.11.3126
10. MORGAN AJ, SCHWARTZ RA. Diabetic dermopathy: A subtle sign with grave implication. J Am Acad Dermatol 2008; 58: 447-451.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2012 Anales del Sistema Sanitario de Navarra
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
La revista Anales del Sistema Sanitario de Navarra es publicada por el Departamento de Salud del Gobierno de Navarra (España), quien conserva los derechos patrimoniales (copyright ) sobre el artículo publicado y favorece y permite la difusión del mismo bajo licencia Creative Commons Reconocimiento-CompartirIgual 4.0 Internacional (CC BY-SA 4.0). Esta licencia permite copiar, usar, difundir, transmitir y exponer públicamente el artículo, siempre que siempre que se cite la autoría y la publicación inicial en Anales del Sistema Sanitario de Navarra, y se distinga la existencia de esta licencia de uso.
